Surgery for intracerebral haemorrhage has never shown a clean overall benefit. This review asks a narrower question: does it matter where the bleed is — deep versus lobar — and is the difference big enough to act on?
ICH is the deadliest subtype of stroke, and the two largest craniotomy trials — STICH and STICH-2 — found no clear overall functional benefit. A post-hoc signal in STICH suggested superficial lobar bleeds might do better with surgery; that single observation shaped the design of STICH-2.
The minimally invasive generation has revived the question without settling it. ENRICH showed benefit concentrated in lobar haemorrhage; MISTIE III and MIND 2025 found no overall benefit. Deep and lobar bleeds have different pathology — hypertensive small-vessel disease versus cerebral amyloid angiopathy — so a location effect is biologically plausible.
The most recent meta-analysis in this space excluded conventional craniotomy trials, leaving out STICH-2 — the only randomised trial with a purely lobar population — and reported no formal test for subgroup interaction. This review pools both surgical generations and tests the interaction directly.
These are the figures from the submitted manuscript. It hasn't completed peer review yet, so numbers may still change — please wait for the published version before citing them.
In deep haemorrhage, evacuation is associated with a higher rate of favourable functional outcome.
In lobar haemorrhage the direction is the same but the interval crosses one — consistent with benefit, not yet demonstrating it.
The formal test — within-trial ratios only, so randomisation is preserved — does not show that location modifies the surgical effect. The subgroup contrast people have been reading into this literature does not survive it.